Highlights
About
Nasal Delivery of Cannabis-derived Therapeutics
Brainose Technologies has developed a nose-to-brain delivery system for cannabis-derived therapeutics for the treatment of central nervous system (CNS) indications. Brainose is currently developing a pharmaceutical-grade cannabinoid-based therapy with a focus on pain management for FDA and CE approval in the U.S. and Europe. The companys mission is to provide the huge population that benefits from cannabis-derived therapeutics with accessibility to these medications in a simple, safe, efficient, and friendly manner. Its products are designed to ensure precise and reproducible dose delivery. Brainose was founded as a collaboration between Cann10, an accelerator focused on medical cannabis, and Nextar Chempharma Solutions, a veteran pharmaceutical company. Brainose has partnered with SipNose to further progress on its drug delivery platform.
Identity
| Name | Brainose Technologies |
|---|---|
| Slug | brainose |
| Type / kind | startup |
| Crunchbase ID | brainose-technologies |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoJ3is5sJDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Mar 2019 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Rosh Haayin |
| HQ address | HaMelacha St 22, Rosh Haayin, Israel |
Classifications
Funding
| Total raised | — |
|---|---|
| Current stage | Pre-Funding |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}